Is there a preferred first-line therapy for metastatic renal cell carcinoma? A network meta-analysis.

A customized approach for the first-line treatment of patients with mRCC should consider the risk/benefit profile of each treatment option, especially considering the likeliness of long-term survival finally reached in this setting.